Atorvastatin for protease inhibitor-related hyperlipidaemia

被引:38
|
作者
Murillas, J [1 ]
Martín, T [1 ]
Ramos, A [1 ]
Portero, JL [1 ]
机构
[1] Hosp Clin Puerta Hierro, Madrid, Spain
关键词
D O I
10.1097/00002030-199907300-00030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1424 / 1425
页数:2
相关论文
共 50 条
  • [2] Bezafibrate, gemfibrozil, fenofibrate, atorvastatin or pravastatin as treatment for protease inhibitor-related hyperlipidaemia in patients with HIV infection
    Calza, L
    Manfredi, R
    Chiodo, F
    XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 169 - 173
  • [3] HIV protease inhibitor-related lipodystrophy syndrome
    Carr, A
    CLINICAL INFECTIOUS DISEASES, 2000, 30 : S135 - S142
  • [4] The use of therapeutic drug monitoring in the management of protease inhibitor-related toxicity
    Forsyth, SF
    French, PD
    Macfarlane, E
    Gibbons, SE
    Miller, RF
    INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (02) : 139 - 141
  • [5] Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities
    Henry, K
    Melroe, H
    Huebesch, J
    Hermundson, J
    Simpson, J
    LANCET, 1998, 352 (9133): : 1031 - 1032
  • [6] Protease inhibitor-related paronychia, ingrown toenails, desquamative cheilitis and cutaneous xerosis
    García-Silva, J
    Almagro, M
    Juega, J
    Peña, C
    López-Calvo, S
    del Pozo, J
    Fonseca, E
    AIDS, 2000, 14 (09) : 1289 - 1291
  • [8] ApoE genotype and protease-inhibitor-associated hyperlipidaemia
    Behrens, G
    Schmidt, HHJ
    Stoll, M
    Schmidt, RE
    LANCET, 1999, 354 (9172): : 76 - 76
  • [9] MEK inhibitor-related rhabdomyolysis
    Koeppen, S.
    Schilling, B.
    Zimmer, L.
    Schadendorf, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 62 - 62